Correction: Tamsulosin-Induced Gynecomastia: Reversible Adverse Effect

• August 18, 2026

Beyond lipids: a precision prevention blueprint for China's residual risk

• by Ming Chi, Taoming Qian, Jirong Zhang, Weiqing Qiao, Juan Jin

• August 17, 2026

Translating Continuous Glucose Monitoring Alarms Into Clinical Practice—Beyond Efficacy

• by Eileen R. Faulds

• August 20, 2026

HHS Proposes Mandatory GRAS Notices

Manufacturers would be required to notify the FDA of GRAS determinations under a proposed rule, while HHS and USDA also submitted the first proposed federal definition of ultra-processed foods for final review.

• by Kathryn Wighton

• August 10, 2026

• 3 min